Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/16/2018 05/17/2018 05/18/2018 05/21/2018 05/22/2018 Date
35.68(c) 35.71(c) 35.64(c) 35.8(c) 35.72 Last
20 750 225 12 354 300 14 928 519 16 890 829 13 735 575 Volume
-0.03% +0.08% -0.20% +0.45% -0.22% Change
More quotes
Financials (USD)
Sales 2018 54 391 M
EBIT 2018 20 753 M
Net income 2018 12 828 M
Debt 2018 21 840 M
Yield 2018 3,82%
Sales 2019 55 127 M
EBIT 2019 21 446 M
Net income 2019 13 827 M
Debt 2019 14 767 M
Yield 2019 4,07%
P/E ratio 2018 15,94
P/E ratio 2019 15,18
EV / Sales2018 4,23x
EV / Sales2019 4,05x
Capitalization 208 B
More Financials
Company
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare.It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments.The IH segment focuses on the development and... 
Sector
Pharmaceuticals
Calendar
07/31Earnings Release
More about the company
Surperformance© ratings of Pfizer
Trading Rating : Investor Rating :
More Ratings
Latest news on PFIZER
05/22PFIZER : A Study Analyzing Observational Data Shows Real-World Effectiveness of ..
BU
05/22ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/..
AQ
05/22PFIZER : Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) ..
BU
05/22AMERISOURCEBERGEN : AG Wilson Joins Walgreens to Announce Expansion of Safe Medi..
AQ
05/22PFIZER : The New York Academy of Medicine to Honor Dr. Freda Lewis-Hall and Dr. ..
AQ
05/22Group identifies six core outcomes for hemophilia gene therapies
AQ
05/21PFIZER INC. : - LYRICA Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meet..
AQ
05/21EU Approves GlaxoSmithKline JV's Juluca HIV Treatment
DJ
05/21VIIV HEALTHCARE : Receives EU Marketing Authorisation for Juluca (dolutegravir/r..
BU
05/21KARO PHARMA : Receives milestone payment for rorgamma project from pfizer
AQ
More news
Sector news : Pharmaceuticals - NEC
05/22VALEANT PHARMACEUTICALS INTL : Ex-Valeant, Philidor executives convicted of kick..
RE
05/22VALEANT PHARMACEUTICALS INTL : Former Valeant Executive Found Guilty on Charges ..
DJ
05/22SHIRE PLC SHIRE PLC : Director Declaration
DJ
05/22BAYER : Indian regulator clears Bayer's deal for Monsanto
RE
05/22SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on PFIZER 
PFIZER INC. - 2016
Expectation of a turn-around
BUY
PFIZER INC. - 2016
Back on a long term support level
BUY
More Strategies
Latest Tweets
01:18aCritical Condition: Inside Pfizer’s Drug Supply Problem: How a much-touted ac.. 
12:15aJ&J, Pfizer, Merck again lead pharma in Fortune 500: Johnson & Jo.. 
05/22$DRUS MOST VOL iN ITS HISTORY 2DAY? ? $BAC $GE $BMY $WFC $MU $YNDX $AMD $OCL..
1
05/22$DRUS .026 U CAN'T IGNORE THE WHALE BUYS TODAY!?? 52WKLOW!? $BAC $GE $BMY $WF.. 
05/22BREAKING Gas leak shuts down John Young Parkway between Princeton, Silver Sta..
3
More tweets
Qtime:465
News from SeekingAlpha
05/22Entera Bio Re-Enters IPO Process 
05/22GOLDMAN SACHS : Hedge funds betting against Nvidia, Intel 
05/22Spark's gene therapy SPK-9001 shows treatment benefit in hemophilia B study 
05/22DIVIDEND SENSEI'S PORTFOLIO UPDATE 3 : If You Want To Get Rich, Follow The Data 
05/21CELLECTIS : Will Focus On Universal CAR-T Payoff? 
Chart PFIZER
Duration : Period :
Pfizer Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Technical analysis trends PFIZER
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 39,6 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Albert Bourla Chief Operating Officer & Director
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
W. Don Cornwell Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER-1.16%208 479
JOHNSON & JOHNSON-11.45%333 230
NOVARTIS-6.55%202 002
ROCHE HOLDING LTD.-8.90%195 055
MERCK AND COMPANY5.10%159 105
AMGEN1.38%116 659